Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accent Resources NL | A2R | Sep 20, 2024 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Sep 20, 2024 | 0.02 | +10.00 |
Accentro Real Estate AG | A4Y | Sep 20, 2024 | 0.48 | +0.85 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Sep 20, 2024 | 300.20 | +0.12 |
Accesso Technology Group Plc | LQG | Sep 20, 2024 | 6.05 | +1.68 |
Acciona SA | AJ3 | Sep 20, 2024 | 128.20 | -3.25 |
Acco Brands Corporation | A3B | Sep 20, 2024 | 4.82 | +0.42 |
Accolade, Inc. | 4NE1 | Sep 20, 2024 | 3.72 | -0.53 |
Acconeer | 2LU | Sep 20, 2024 | 0.64 | +3.40 |
Accor | ACR1 | Sep 20, 2024 | 7.80 | +1.96 |
Accor SA | ACR | Sep 20, 2024 | 39.38 | +0.59 |
Accsys Technologies | 1D8 | Sep 20, 2024 | 0.59 | -1.34 |
Accuray Incorporated | XEJ | Sep 20, 2024 | 1.67 | -1.76 |
Ace Hardware Indonesia TBK | 4AH1 | Sep 20, 2024 | 0.04 | +7.69 |
ACE LIBERTY+STONE LS -,25 | 8MW | Sep 20, 2024 | 0.56 | 0.00 |
ACEA SpA | DCA | Sep 20, 2024 | 17.03 | -0.82 |
AcelRx Pharmaceuticals | R5XA | Sep 20, 2024 | 0.82 | +3.38 |
Acer Incorporated | AC5G | Sep 20, 2024 | 4.50 | 0.00 |
ACERINOX ADR 1/2/EO-,25 | ACE | Sep 20, 2024 | 4.66 | +5.43 |
Acerinox SA | ACE1 | Sep 20, 2024 | 9.57 | -0.42 |
Achieve Life Sciences, Inc. - | SP4P | Sep 20, 2024 | 3.98 | +3.38 |
Achilles Therapeutics plc - American Depositary Shares | 698 | Sep 20, 2024 | 0.81 | -0.61 |
ACI Worldwide, Inc. | TSA | Sep 20, 2024 | 44.00 | -0.90 |
ACINQUE S.P.A. EO 1 | YA2 | Sep 20, 2024 | 1.94 | -0.51 |
Ackermans & van Haaren NV | B3K | Sep 20, 2024 | 190.50 | +0.63 |
Aclara Resources Inc | JD1 | Sep 20, 2024 | 0.31 | +8.33 |
Aclaris Therapeutics, Inc. | 8AT | Sep 20, 2024 | 1.05 | +0.72 |
ACM Research, Inc. - Class A | 813 | Sep 20, 2024 | 15.40 | +4.55 |
Acma Ltd | AAX1 | Sep 20, 2024 | 0.01 | +4.35 |
Acme United Corporation. | UT1 | Sep 20, 2024 | 36.80 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.